TY - JOUR
T1 - Optical Control of Cardiac Function with a Photoswitchable Muscarinic Agonist
AU - Riefolo, Fabio
AU - Matera, Carlo
AU - Garrido-Charles, Aida
AU - Gomila, Alexandre M.J.
AU - Sortino, Rosalba
AU - Agnetta, Luca
AU - Claro, Enrique
AU - Masgrau, Roser
AU - Holzgrabe, Ulrike
AU - Batlle, Montserrat
AU - Decker, Michael
AU - Guasch, Eduard
AU - Gorostiza, Pau
PY - 2019/5/8
Y1 - 2019/5/8
N2 - Copyright © 2019 American Chemical Society. Light-triggered reversible modulation of physiological functions offers the promise of enabling on-demand spatiotemporally controlled therapeutic interventions. Optogenetics has been successfully implemented in the heart, but significant barriers to its use in the clinic remain, such as the need for genetic transfection. Herein, we present a method to modulate cardiac function with light through a photoswitchable compound and without genetic manipulation. The molecule, named PAI, was designed by introduction of a photoswitch into the molecular structure of an M2 mAChR agonist. In vitro assays revealed that PAI enables light-dependent activation of M2 mAChRs. To validate the method, we show that PAI photoisomers display different cardiac effects in a mammalian animal model, and demonstrate reversible, real-time photocontrol of cardiac function in translucent wildtype tadpoles. PAI can also effectively activate M2 receptors using two-photon excitation with near-infrared light, which overcomes the scattering and low penetration of short-wavelength illumination, and offers new opportunities for intravital imaging and control of cardiac function.
AB - Copyright © 2019 American Chemical Society. Light-triggered reversible modulation of physiological functions offers the promise of enabling on-demand spatiotemporally controlled therapeutic interventions. Optogenetics has been successfully implemented in the heart, but significant barriers to its use in the clinic remain, such as the need for genetic transfection. Herein, we present a method to modulate cardiac function with light through a photoswitchable compound and without genetic manipulation. The molecule, named PAI, was designed by introduction of a photoswitch into the molecular structure of an M2 mAChR agonist. In vitro assays revealed that PAI enables light-dependent activation of M2 mAChRs. To validate the method, we show that PAI photoisomers display different cardiac effects in a mammalian animal model, and demonstrate reversible, real-time photocontrol of cardiac function in translucent wildtype tadpoles. PAI can also effectively activate M2 receptors using two-photon excitation with near-infrared light, which overcomes the scattering and low penetration of short-wavelength illumination, and offers new opportunities for intravital imaging and control of cardiac function.
KW - ABSORPTION
KW - DESIGN
KW - HEART
KW - LIGANDS
KW - LIGHT
KW - OPTOGENETICS
KW - PROTEIN-COUPLED RECEPTORS
KW - ROADMAP
UR - http://www.mendeley.com/research/optical-control-cardiac-function-photoswitchable-muscarinic-agonist
U2 - 10.1021/jacs.9b03505
DO - 10.1021/jacs.9b03505
M3 - Article
C2 - 31010281
SN - 0002-7863
VL - 141
SP - 7628
EP - 7636
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 18
ER -